Cleveland, Ohio • Velocity Clinical Research
Phone: (216) 682-0320
Alzheimer’s disease (AD) is a progressive disease. It is characterized by a loss of cognitive abilities. In early stages, memory loss is mild, but symptoms worsen over time. Several behavioral disorders can affect patients with AD such as agitation, anxiety, disturbance of sleep cycle, and irritability among others. These behavioral disorders affect the quality of life in patients with AD and can cause emotional turmoil for caregivers.
Velocity is conducting a clinical research study for an investigational medication for agitation in patients living with Alzheimer’s disease at no cost to participants.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy